Group One Trading’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-43,294
Closed -$1.01M 5741
2018
Q3
$1.29M Buy
43,294
+14,410
+50% +$543K 0.01% 1486
2018
Q2
$1.06M Sell
28,884
-23,150
-44% -$752K 0.01% 1673
2018
Q1
$1.71M Sell
52,034
-15,795
-23% -$494K 0.02% 1118
2017
Q4
$1.85M Sell
67,829
-31,312
-32% -$964K 0.01% 1234
2017
Q3
$3.67M Buy
99,141
+5,376
+6% +$198K 0.03% 660
2017
Q2
$3.56M Buy
93,765
+19,242
+26% +$857K 0.04% 630
2017
Q1
$3.64M Buy
+74,523
New +$3.4M 0.04% 544
2016
Q4
Sell
-2,019
Closed -$71.6K 5055
2016
Q3
$76K Sell
2,019
-24,056
-92% -$907K ﹤0.01% 3102
2016
Q2
$877K Sell
26,075
-13,908
-35% -$490K 0.01% 1342
2016
Q1
$1.27M Buy
39,983
+15,642
+64% +$511K 0.02% 1019
2015
Q4
$909K Buy
24,341
+22,463
+1,196% +$849K 0.01% 1372
2015
Q3
$71K Sell
1,878
-32,429
-95% -$1.14M ﹤0.01% 3301
2015
Q2
$982K Buy
34,307
+23,081
+206% +$643K 0.01% 1226
2015
Q1
$315K Buy
+11,226
New +$315K ﹤0.01% 1995
2014
Q4
Sell
-8,606
Closed -$213K 5474
2014
Q3
$192K Buy
8,606
+5,943
+223% +$151K ﹤0.01% 2400
2014
Q2
$77K Buy
2,663
+263
+11% +$7.02K ﹤0.01% 3224
2014
Q1
$68K Buy
+2,400
New +$79.4K ﹤0.01% 3401

Other funds holding MDCO

Group One Trading's MDCO Position: Q4 2018 in Review

Group One Trading sold out of Medicines Co (MDCO) in Q4 2018, closing a stake of 43,294 shares — an estimated $1.01M sold.

Group One Trading first reported a position in MDCO in Q1 2014 and held it in 17 quarters. The position peaked at $3.67M in Q3 2017. 188 funds tracked by Wall St. Rank hold MDCO as of Q4 2018.

  • Group One Trading reported no remaining Medicines Co position as of Q4 2018 after selling out during the quarter.
  • Group One Trading sold 43,294 Medicines Co shares in Q4 2018, an estimated $1.01M.
  • Group One Trading first reported a position in Medicines Co in Q1 2014 and held it in 17 quarters.
  • Group One Trading's Medicines Co position peaked at $3.67M in Q3 2017.
  • 188 funds tracked by Wall St. Rank held Medicines Co as of Q4 2018.

Based on Group One Trading's 13F filing for Q4 2018, filed 6 Feb 2019.